- Appointed Michael Amoroso as President and Chief Executive Officer and to Board of Directors; Sam Wadsworth , Ph.D., and Shari Lisa Piré, J.D., Appointed to Board of Directors - Hosted In Vivo Gene Editing R&D Event and Outlined Plans for Accelerated Path to Clinic for Three Investigational New